Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 29% ± 14% | |
macrophage | 11 studies | 40% ± 17% | |
glutamatergic neuron | 10 studies | 43% ± 21% | |
microglial cell | 8 studies | 47% ± 10% | |
GABAergic neuron | 7 studies | 42% ± 20% | |
oligodendrocyte precursor cell | 7 studies | 29% ± 11% | |
adipocyte | 6 studies | 23% ± 2% | |
cardiac muscle cell | 6 studies | 57% ± 23% | |
dendritic cell | 6 studies | 30% ± 9% | |
T cell | 6 studies | 30% ± 10% | |
myeloid cell | 6 studies | 31% ± 10% | |
natural killer cell | 5 studies | 38% ± 12% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 26% ± 12% | |
interneuron | 5 studies | 54% ± 18% | |
B cell | 5 studies | 36% ± 11% | |
monocyte | 5 studies | 39% ± 12% | |
fibroblast | 5 studies | 28% ± 7% | |
CD4-positive, alpha-beta T cell | 4 studies | 29% ± 8% | |
neuron | 4 studies | 35% ± 5% | |
granule cell | 4 studies | 42% ± 12% | |
pericyte | 4 studies | 36% ± 14% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 26% ± 13% | |
retina horizontal cell | 4 studies | 21% ± 8% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 31% ± 8% | |
progenitor cell | 3 studies | 29% ± 5% | |
plasma cell | 3 studies | 30% ± 6% | |
CD8-positive, alpha-beta T cell | 3 studies | 28% ± 5% | |
amacrine cell | 3 studies | 39% ± 13% | |
glycinergic amacrine cell | 3 studies | 48% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 25% ± 12% | |
alveolar macrophage | 3 studies | 33% ± 8% | |
lymphocyte | 3 studies | 55% ± 13% | |
smooth muscle cell | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1093.21 | 89 / 89 | 97% | 13.98 | 871 / 901 |
adrenal gland | 100% | 2106.70 | 258 / 258 | 95% | 15.72 | 219 / 230 |
brain | 93% | 1419.93 | 2454 / 2642 | 100% | 13.83 | 704 / 705 |
pancreas | 97% | 685.57 | 318 / 328 | 96% | 10.60 | 170 / 178 |
breast | 100% | 1188.78 | 459 / 459 | 86% | 5.97 | 964 / 1118 |
lung | 99% | 941.02 | 573 / 578 | 81% | 4.92 | 930 / 1155 |
stomach | 99% | 745.83 | 357 / 359 | 77% | 5.19 | 221 / 286 |
thymus | 98% | 775.10 | 643 / 653 | 78% | 4.51 | 473 / 605 |
liver | 87% | 471.06 | 197 / 226 | 87% | 6.58 | 353 / 406 |
ovary | 100% | 2054.09 | 180 / 180 | 66% | 3.06 | 284 / 430 |
uterus | 99% | 1016.98 | 169 / 170 | 66% | 4.88 | 304 / 459 |
intestine | 94% | 936.46 | 904 / 966 | 68% | 4.77 | 356 / 527 |
bladder | 95% | 438.67 | 20 / 21 | 62% | 3.81 | 312 / 504 |
prostate | 94% | 626.89 | 231 / 245 | 59% | 2.23 | 297 / 502 |
skin | 65% | 562.12 | 1178 / 1809 | 68% | 4.42 | 321 / 472 |
esophagus | 53% | 256.79 | 771 / 1445 | 62% | 3.98 | 113 / 183 |
adipose | 100% | 1356.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.83 | 29 / 29 |
muscle | 100% | 2828.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2423.51 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2451.58 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 798.20 | 1310 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 2108.37 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.42 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 29% | 0.99 | 23 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050859 | Biological process | negative regulation of B cell receptor signaling pathway |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_0032228 | Biological process | regulation of synaptic transmission, GABAergic |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0006629 | Biological process | lipid metabolic process |
GO_0002322 | Biological process | B cell proliferation involved in immune response |
GO_0002337 | Biological process | B-1a B cell differentiation |
GO_0005737 | Cellular component | cytoplasm |
GO_0070679 | Molecular function | inositol 1,4,5 trisphosphate binding |
GO_0050811 | Molecular function | GABA receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0004435 | Molecular function | phosphatidylinositol phospholipase C activity |
Gene name | PLCL2 |
Protein name | Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2) Phosphoinositide phospholipase C (EC 3.1.4.11) |
Synonyms | KIAA1092 PLCE2 |
Description | FUNCTION: May play an role in the regulation of Ins(1,4,5)P3 around the endoplasmic reticulum. . |
Accessions | ENST00000615277.5 [Q9UPR0-1] ENST00000419842.1 ENST00000432376.5 [Q9UPR0-3] Q9UPR0 ENST00000638327.1 [Q9UPR0-3] ENST00000638466.2 [Q9UPR0-1] H7C276 |